Mdm2-p53 inhibitors (Silicos NV)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameMdm2-p53 inhibitors (Silicos NV)
Drug Alias NameSIL-43
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionp53-binding protein Mdm-2 inhibitors
Targetsp53-binding protein Mdm-2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSilicos NV
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSilicos NV
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A